HACE1 and lung cancer: Indeed, overexpression of OPTN in lung cancer cell lines results in a 63% reduction in proliferation, while in vivo studies show that tumors in OPTN-HACE1-expressing cells are five times smaller than in cells lacking these proteins [4].